Merck to seek authorization for oral Covid drug

Pharmaceutical company Merck said Friday it will seek authorization in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.